Can-Fite BioPharma (CANF) Reports FY22, Provides Clinical Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- US stock futures gain as oil pulls back ahead of Fed decision
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
| CAN-FITE BIOPHARMA LTD. (NYSE: CANF) | Delayed: 1.72 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.72 | 52 Week High | $3.89 | |||
| Open | $1.72 | 52 Week Low | $1.85 | |||
| Day High | $1.72 | P/E | N/A | |||
| Day Low | $1.72 | EPS | $0.00 | |||
| Volume | 4,941 | |||||
